Percutaneous arterial aortoiliac intervention

Area of Science:

• Vascular Surgery
• Endovascular Interventions
• Aortoiliac Disease Treatment

Background:

• Reconstructive vascular surgery, specifically aortobifemoral bypass, has been a primary treatment for obliterative aortoiliac disease.
• Surgical interventions yield 5-year patency rates of 85-90% and 10-year rates of 70-75%, with operative mortality of 1.6-3.3% and systemic morbidity of 8.3%.
• Traditional indications are limited to severe claudication and limb-threatening ischemia due to significant procedural risks.

Purpose of the Study:

• To evaluate the evolving role of endovascular techniques in treating aortoiliac disease.
• To compare the risks and benefits of percutaneous interventions versus traditional surgical reconstruction.
• To explore expanded indications for endovascular treatment of aortoiliac occlusive disease.

Main Methods:

• Review of outcomes for balloon angioplasty and endovascular stenting in aortoiliac disease.
• Comparison of percutaneous intervention data with historical surgical outcomes.
• Analysis of evolving technologies and limited randomized studies in endovascular aortoiliac interventions.

Main Results:

• Endovascular stenting and balloon angioplasty are effective modalities for aortoiliac disease, offering lower risk compared to surgery.
• These less invasive procedures allow for broader indications beyond severe ischemia.
• Predictable outcomes and acceptable secondary patency rates support the preference for percutaneous interventions.

Conclusions:

• Endovascular interventions are increasingly preferred over traditional surgery for aortoiliac disease due to lower complication rates.
• Evolving endovascular technologies are expanding treatment options and improving outcomes.
• Percutaneous approaches offer a safer alternative when outcomes are predictable and secondary patency is acceptable.